becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency green-lighted Eli Lilly’s Zepbound drug for the use, approving a prescription medicine ...
The U.S. Food and Drug Administration has approved Eli Lilly and Co. ’s obesity-treatment Zepbound as the first medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. Lilly ...